The SOX2-CHD7 helicase network and human disease. In neural stem cells, a SOX2-CHD7 complex regulates the transcription of genes mutated in the human genetic diseases Alagille syndrome, Feingold syndrome and Pallister-Hall syndrome. 
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these traits individually, but to date, no loci have been found that affect the entire spectrum of metabolic syndrome traits. Variants near KLF14, which encodes the transcription factor Krüppel-like Factor 14, have previously been associated with T2D and HDL cholesterol levels in large GWAS analyses, and the same SNPs were found to be associated with KLF14 expression in adipose tissue, indicating the presence of a cis eQTL (Fig. 1a) 7, 8 . Because KLF14 is a transcription factor, Small et al. 5 reasoned that the cis eQTL near KLF14 may influence the expression of KLF14 target genes in trans (Fig. 1a) . They examined this possibility using subcutaneous adipose biopsies from 776 female twins of European ancestry as well as a smaller replication sample. In support of their hypothesis, they identified ten genes that had genome-wide significant trans association with the same SNP that regulates KLF14 expression in cis (Fig. 1b) . Interestingly, expression levels of to prioritize candidate genes at loci identified in genome-wide association studies (GWAS) 3 and to study the nature of gene-environment interactions 4 . On page 561 of this issue, Tim Spector, Mark McCarthy and colleagues 5 report a trans regulatory network based on eQTL analyses that connects multiple loci for metabolic syndrome, a condition characterized by a clustering of metabolic disturbances associated with cardiovascular disease and diabetes.
Trans regulatory network
The physiological disturbances of metabolic syndrome include abdominal obesity, insulin resistance, elevated low density lipoprotein (LDL), elevated triglycerides, reduced high density lipoproteins (HDL), hypertension and type 2 diabetes (T2D). Although environmental factors, particularly caloric excess and physical inactivity, play a major role in metabolic syndrome, the traits are highly heritable 6 . GWAS have identified numerous loci influencing Any natural population is likely to harbor many thousands of common variants influencing gene expression, just as there are common variants affecting protein sequences. Such variation can be examined globally by measuring transcript levels using microarrays or nextgeneration sequencing and, like other genetic traits, can be mapped using linkage or association. The loci thus identified are termed expression quantitative trait loci (eQTLs) 1 . Over the past decade, eQTLs have been studied in many species and have proven particularly useful in the analysis of complex traits. For example, they have been used to model causal interactions 2 
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Paternal the ten genes were associated with a variety of metabolic syndrome traits, including obesity, dyslipidemias and measures of insulin resistance, supporting a trans causal link between KLF14 expression and these ten genes. When the authors relaxed the significance threshold for their trans eQTL analysis, they defined a set of 46 trans-associated genes and found that this larger gene set was enriched for KLF transcription factor binding sites. Moreover, using largescale GWAS data, they showed that five of the ten genes had nearby SNPs that were associated with metabolic syndrome traits at genome-wide significance (Fig. 1b) . Thus, it appears that KLF14 influences the expression of multiple genes that, in turn, mediate the effects of KLF14 on metabolic disease. It is also noteworthy that the traits associated with the regulatory network described by Small et al. 5 include all the key features of metabolic syndrome.
One of the trans-regulated genes, SLC7A10, encodes a protein that mediates the transport of neutral amino acids 9 . Notably, its expression is strongly correlated with several metabolic phenotypes. In addition, two independent SNPs in the SLC7A10 locus are significantly associated with HDL and body mass index (BMI)-adjusted waist-hip ratio. These associations suggest an important role for SLC7A10 in influencing a range of metabolic traits.
Exploring KLF14 function KLF proteins are zinc-finger-containing transcription factors that play important roles in health and disease 10 . Seventeen KLF family members have been identified to date, but relatively little is known about KLF14. KLF14 is unusual in that it is imprinted and expressed only from the maternal allele, suggesting a possible role in growth and development. It also appears to be undergoing accelerated evolution in the human lineage, consistent with positive selection. KLF14 is highly expressed in neurons, and some of its effects may be related to metabolic control in the brain in addition to adipose tissue 11 .
The biological function and detailed role of KLF14 in metabolic syndrome and associated clinical pathologies will need to be further elucidated. One initial challenge will be to identify the mechanism by which variants near KLF14 affect the expression of this gene in cis. Moreover, the effect of KLF14 expression on the trans-associated genes will have to be further examined, perhaps using adipocyte cell culture systems. Genome-wide mapping of KLF14 binding sites should help identify genes regulated by this transcription factor. Klf14 knockout mice may also be useful in understanding the role of this gene in clinical phenotypes associated with metabolic syndrome.
The study by Small et al. 5 leveraged the power of integrative genomics to provide fascinating insights into the role of KLF14 in regulating metabolic syndrome traits. Looking ahead, next generation RNA sequencing approaches are likely to be especially informative in studies such as this, as they could provide information about allele-specific expression in addition to total expression levels 12 . One can also think about integrating transcript levels with data from other high-throughput technologies such as chromatin immunoprecipitation sequencing (ChIP-Seq), proteomics and metabolomics. These types of integrative studies are promising avenues for exploring the mechanistic basis of complex trait associations and their underlying physiology. interacts with the apoptotic protease activating factor 1 (APAF1) and can suppress apoptosis. Decreased apoptosis of neutrophils caused by increased APIP expression may deteriorate pulmonary function in cystic fibrosis by delayed resolution of neutrophilic inflammation. DNA sequencing of APIP and the adjacent EHF in 96 individuals with cystic fibrosis did not reveal any significant variation in the coding sequence. This does not exclude, however, a potential role of APIP in cystic fibrosis airways disease by altered expression levels caused by a change in a regulatory site.
The underlying gene or genes at the second locus on chromosome 20 are more obscure. The authors discuss several candidates, such as the melanocortin 3 receptor (encoded by MC3R), CASS4-HEPL and Aurora kinase A (encoded by AURKA). The latter two might be involved in the regulation of apoptosis.
Different studies, different modifiers
Several genes have been implicated to act as disease modifiers in cystic fibrosis-associated lung disease 8 ( Table 1) . One of the first candidates proposed was MBL2, encoding mannose binding lectin 9, 10 . MBL is a serum protein that belongs to the collectin subgroup of the C-type lectin superfamily. Collectins bind specifically to oligosaccharides on the surface In contrast, pancreatic sufficiency is frequently associated with mild CFTR alterations 5 . In the last two decades, several studies have been performed to dissect the genetic factors involved in cystic fibrosis-related deterioration of lung function.
In this issue, Wright et al. conducted a combined GWAS and linkage study in 3,467 individuals with cystic fibrosis originating from three different study populations: the Genetic Modifier Study (GMS), the Canadian
